Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Online pharmacy offers growth potential for postal group

This article was originally published in Scrip

Executive Summary

TNT Post, the international postal delivery group, is to buy a 35% stake in Sierra Nova, the company that operates the Netherlands' fastest growing online pharmacy, The deal gives the group an interest in the pharmacy and allows it to expand further into internet shopping, says the company. The financial details of the agreement have not been disclosed. The pharmacy, which allows patients to order repeat prescriptions online and have them securely delivered to the home, was launched by TNT in 2007 alongside partners CEVA Logistics and Sierra Nova. 50,000 patients used the pharmacy last year, and it has also proven popular with major health insurers as it is more cost-effective than the traditional pharmacy model, TNT says.

You may also be interested in...

Italy To Consult On Pricing Transparency Requirements

Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.

German Guidelines Seek To Boost Biosimilar Uptake

Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.

European Regulatory Strategy ‘Should Prioritize Real World Evidence’

EFPIA, the European Federation of Pharmaceutical Industries and Associations, has put forward what it thinks the European regulatory network strategy to 2025 should prioritize.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts